#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    KBG syndrome Hypochromic anaemia Scleroderma associated digital ulcer Neuroblastoma recurrent Chronic lymphocytic leukaemia recurrent Arrhythmogenic right ventricular dysplasia Familial haemophagocytic lymphohistiocytosis Soft tissue necrosis Myelodysplastic syndrome Cytomegalovirus infection Neurodermatitis Deafness neurosensory Anaplastic large cell lymphoma T- and null-cell types Malignant peritoneal neoplasm Dermatomyositis More trials…

    Learn about Rare Diseases

    Sarcoma – Life with Disease Phenylketonuria – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Cholangitis sclerosing – Basic Information Mantle cell lymphoma refractory – Diagnostics X-linked lymphoproliferative syndrome – Trials in Disease Primary hyperoxaluria – Life with Disease Pulmonary fibrosis – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Glomerulonephritis rapidly progressive – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evencaleucel Pervi-Neo GSKVX000000070250 Mk-1200 Sonidegib Varegacestat Codeine Phosphate Ropivacaine Oxytocin Synthetic Litifilimab Argon Captopril Nelarabine Camphor Flecainide Dobutamine Hydrochloride Risedronate Sodium Metreleptin Censavudine Inclisiran Sodium More therapies…

    Learn about Your Condition

    Encephalopathy neonatal Benign neoplasm of ureter Lichen planopilaris Uveal melanoma Red blood cell abnormality Von Willebrand's disease Extra-osseous Ewing's sarcoma Haemodynamic instability Prader-Willi syndrome Metastatic neoplasm Genitourinary tract neoplasm Diabetic neuropathy Colorectal adenocarcinoma Ocular lymphoma Hypersensitivity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study on Sibeprenlimab for Patients with IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Sibeprenlimab
    Belgium Croatia Czechia France Germany Greece +6

  • Study of Pembrolizumab, Carboplatin, and Cabazitaxel for Patients with Aggressive Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Cabazitaxel
    • Carboplatin
    • Pembrolizumab
    Spain

  • Study Comparing [177Lu]LU-PSMA-I&T and Hormone Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone Acetate
    • Enzalutamide
    • Lutetium (177Lu) Zadavotide Guraxetan
    France Italy Spain

  • Study on the Effect of Degarelix and Ultrasound Therapy for Patients with Intermediate-Risk Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Degarelix
    Finland

  • Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertonic bladder
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Portugal

  • Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buserelin Acetate
    • Relugolix
    • Degarelix
    Austria Germany
Previous Page
1 … 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!